Nomida.biz
FDA issued a warning letter to Nomida.biz on September 12, 2024, for selling unapproved and misbranded semaglutide and tirzepatide drug products to U.S. consumers via the internet without requiring a prescription. The site marketed these GLP-1 injectable products with claims of safety, effectiveness, and weight loss innovation, despite lacking FDA-approved drug applications for the specific formulations offered. FDA cited violations of the FD&C Act including introduction of unapproved new drugs and misbranding, and demanded corrective action within 15 working days, warning that failure to comply could result in seizure or injunction.
Flagged claims (6)
Semaglutide 5mg ships in a Lyophilized Powder form (>99% purity) in 2ml vial
Find easy, effective methods to manage your weight
To Reconstitute, you need a solvent such as BAC Water (Sold Here)
Nomida is at the Forefront of Weight Loss Innovation
specialize in Semaglutide and Tirzepatide, offering powerful solutions for weight management
products are the next big thing in Weight Loss. They're Safe, Effective, and Designed for Results.
Required actions (3)
We advise you to review your websites, product labels, and other labeling and promotional materials to ensure that you are not misleadingly representing your products as safe and effective for a use for which they have not been approved by FDA and that you are not distributing misbranded products in violation of the FD&C Act.
Please notify this office in writing within 15 working days describing the specific steps you have taken to address any violations and to prevent their recurrence.
Failure to adequately address this matter may result in legal action, including, without limitation, seizure and injunction, without further notice.
Does your site contain similar claims?
The free site audit scans your whole site against every entry in this Atlas. Most glp-1 / weight loss sites match 3-6 patterns.
Run my free site auditWorried about one specific page, ad, or email? Paste it into the free Claim Checker and see what the FDA and FTC would flag, with the precedent next to each one. No email required.
Check specific copy in the Claim Checker